CVS pulls all Zantac, CVS-branded ranitidine products over possible NDMA contamination
CVS has pulled Zantac brand and CVS Health brand ranitidine products after the Food and Drug Administration announced the medication used to treat heartburn could have a low level of nitrosodimethylamine, or NDMA, which is considered a human carcinogen.
But the CVS-branded medications have not officially been recalled, according to CVS.
CVS officials, however, announced the move after the FDA alerted health care professionals to the voluntary recall of some over-the-counter, 75mg and 150mg tablets under the Walgreens, Walmart and Rite-aid brands and all made by Apotex Corp.
Prescription ranitidine hydrochloride capsules made by Sandoz Inc. were also recalled last week due to an NDMA impurity, according to the FDA.
If you have purchased the Zantac brand or the CVS brand ranitidine products and would like to return them, you can take them back to CVS for a refund.
Other H2 blockers are still available at the drug store chain including Pepcid, Tagamet and the generic versions, CVS said.
